Subscribe

Snapshot

DOI:

Effects of age on microvascular function; clinical value of a resistance index in stable angina; vulnerable plaques and adverse events; viewpoints and original research on left atrial appendage occlusion including long-term durability data of the Amplatzer Amulet; and more

From perspectives on left atrial appendage occlusions or original research on the effects of ageing or diabetes and vulnerable plaque to chimney/snorkel stenting during TAV-in-TAV – there’s something for everyone in this issue of EuroIntervention...take a look.

Effects of age on microvascular function

Tijn P.J. Jansen, Peter Damman and colleagues use continuous thermodilution to assess whether age has an effect on microvascular function in patients with normal coronary arteries. They demonstrate an age-dependent increase in hyperaemic microvascular resistance and a decrease in microvascular function, with the latter most evident in patients with smooth coronary arteries.

Clinical value of HSR in stable angina

By using the combined assessment of pressure and flow, the hyperaemic stenosis resistance index may overcome some of the limitations of conventional physiological indices. Vulnerable plaque features and adverse events confirm that hyperaemic stenosis resistance improves the diagnostic accuracy of the detection of ischaemia-inducing lesions and has an important prognostic value for the long-term risk of target vessel failure.

Vulnerable plaque features and adverse events

David del Val, Elvin Kedhi and colleagues examine the prognostic impact of optical coherence tomography-detected vulnerability features (OCT-VFs), either individually or in combination, in predicting the incidence of the lesion-oriented composite endpoint (LOCE) in diabetic patients with non- ischaemic lesions. Thin-cap fibroatheroma was the strongest single predictor of future LOCE events but the risk increased significantly with the simultaneous presence of four OCT-VFs.

Long-term LAAO safety with the Amplatzer Amulet

Lasse Hubertus Tiroke, Jens Erik Nielsen- Kudsk and colleagues evaluate the long- term safety and durability of the Amplatzer Amulet device after left atrial appendage occlusion. Their results suggest that the prevalence and size of peridevice leakage remain stable over time and rarely seal up or progress, underlining the importance of the immediate procedural outcome.

Volume 20 Number 11
Jun 3, 2024
Volume 20 Number 11
View full issue

Suggested by Cory

Debate

10.4244/EIJ-E-25-00009 Jun 16, 2025
Guideline recommendations for QFR should be revisited: pros and cons
Fearon W and Biscaglia S

Flashlight

10.4244/EIJ-D-24-00795 Jun 16, 2025
Transcaval transcatheter aortic valve implantation via left-sided venous access
Doyle C and Casserly I

Letter to the editor

10.4244/EIJ-D-25-00325 Jun 16, 2025
Reply: Completeness or complexity? A nuanced reflection on multivessel revascularisation
Laudani C et al
free

Letter to the editor

10.4244/EIJ-D-25-00197 Jun 16, 2025
Letter: Completeness or complexity? A nuanced reflection on multivessel revascularisation
Sticchi A and Biondi-Zoccai G
free

Research Correspondence

10.4244/EIJ-D-24-01048 Jun 16, 2025
Next-day and 48-hour discharge following alternative access for transcatheter aortic valve implantation
Zendo Y et al
Trending articles
310.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
172.05

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
76.25

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
35

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
Chat with Cory
Hello , I'm Cory and I will do my best to answer your questions about this article. Please remember that this is an experimental feature, and that I'm still learning.
Can you provide a summary of the key findings in this article?
Can you extract and explain the primary hypothesis or research question addressed in this article?
What are the potential clinical applications or implications of the results presented in this paper?
How does this research contribute to our current understanding of cardiovascular disease management?
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved